| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Oncology, Department of Pathology, College of Physicians and Surgeons of Columbia University, New York 10032 [B. H. Y., R. D. F.], and Cell Biology and Genetics Program and The Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York 10021 [P. H. R., R. S. K. C.], New York
Chromosomal translocations involving band 3q27 and various chromosomal sites, including the sites of the immunoglobulin (Ig) loci (14q32, 2p12, 22q11), represent recurrent aberrations in non-Hodgkin's lymphoma (NHL). In order to identify the putative protooncogene involved in these translocations, we have cloned the breakpoints from two B-cell NHL cases carrying t(3;14)(q27;q32) translocations by screening genomic DNA libraries constructed from NHL biopsy samples with immunoglobulin probes. Several recombinant phages have been obtained from each case and shown to contain sequences from both 14q32 and 3q27 by fluorescence in situ hybridization mapping on metaphase chromosomes. In both cases, the translocation breakpoints were found within the switch region of the Ig heavy-chain locus on 14q32 and within the same 3-kilobase region on 3q27. When used in Southern blot hybridization, a probe from the 3q27 region detected rearrangements in an additional five NHL cases carrying 3q27 translocations with 14q32 or other genomic sites. The same probe detected a predominant 2.4-kilobase mRNA species in several lymphoid cell lines analyzed by Northern blot hybridization. These data suggest that chromosomal breakpoints in 3q27 cluster in the proximity of a transcribed gene which represents a candidate protooncogene (bcl-6) involved in B-cell NHL pathogenesis.
1 Supported by Grants CA-44029 (R. D. F.), CA-34775, and CA-08748 (R. S. K. C.) from the NIH.
2 To whom requests for reprints should be addressed.
Received 4/15/93. Accepted 5/12/93.
This article has been cited by other articles:
|
|
 |
|
  L. M. Mendez, J. M. Polo, J. J. Yu, M. Krupski, B. B. Ding, A. Melnick, and B. H. Ye CtBP Is an Essential Corepressor for BCL6 Autoregulation Mol. Cell. Biol., April 1, 2008; 28(7): 2175 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Boccellato, E. Anastasiadou, P. Rosato, B. Kempkes, L. Frati, A. Faggioni, and P. Trivedi EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells J. Virol., March 1, 2007; 81(5): 2274 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Miles, D. K. Crockett, M. S. Lim, and K. S. J. Elenitoba-Johnson Analysis of BCL6-interacting Proteins by Tandem Mass Spectrometry Mol. Cell. Proteomics, December 1, 2005; 4(12): 1898 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. O'Connor Targeting Histones and Proteasomes: New Strategies for the Treatment of Lymphoma J. Clin. Oncol., September 10, 2005; 23(26): 6429 - 6436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Abramson and M. A. Shipp Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach Blood, August 15, 2005; 106(4): 1164 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Harris, J. Mostecki, and P. B. Rothman Repression of an Interleukin-4-responsive Promoter Requires Cooperative BCL-6 Function J. Biol. Chem., April 1, 2005; 280(13): 13114 - 13121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fujimura, Y. Matsudo, M. Kang, Y. Takamori, T. Tokuhisa, and M. Hatano Protective role of Nd1 in doxorubicin-induced cardiotoxicity Cardiovasc Res, November 1, 2004; 64(2): 315 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Katzenberger, G. Ott, T. Klein, J. Kalla, H. K. Muller-Hermelink, and M. M. Ott Cytogenetic Alterations Affecting BCL6 Are Predominantly Found in Follicular Lymphomas Grade 3B with a Diffuse Large B-Cell Component Am. J. Pathol., August 1, 2004; 165(2): 481 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Niu, G. Cattoretti, and R. Dalla-Favera BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells J. Exp. Med., July 21, 2003; 198(2): 211 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pasqualucci, A. Migliazza, K. Basso, J. Houldsworth, R. S. K. Chaganti, and R. Dalla-Favera Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma Blood, April 15, 2003; 101(8): 2914 - 2923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Bosga-Bouwer, G. W. van Imhoff, R. Boonstra, A. van der Veen, E. Haralambieva, A. van den Berg, B. de Jong, V. Krause, M. C. Palmer, R. Coupland, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive Blood, February 1, 2003; 101(3): 1149 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Nakamura, T Matsumoto, S Nakamura, Y Jo, K Fujisawa, H Suekane, T Yao, M Tsuneyoshi, and M Iida Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma J. Clin. Pathol., January 1, 2003; 56(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sasagawa, Y. Matsudo, M. Kang, L. Fujimura, Y. Iitsuka, S. Okada, T. Ochiai, T. Tokuhisa, and M. Hatano Identification of Nd1, a Novel Murine Kelch Family Protein, Involved in Stabilization of Actin Filaments J. Biol. Chem., November 8, 2002; 277(46): 44140 - 44146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Franke, I. Wlodarska, B. Maes, P. Vandenberghe, J. Delabie, A. Hagemeijer, and C. De Wolf-Peeters Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances Blood, March 15, 2001; 97(6): 1845 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Huynh, W. Fischle, E. Verdin, and V. J. Bardwell BCoR, a novel corepressor involved in BCL-6 repression Genes & Dev., July 15, 2000; 14(14): 1810 - 1823. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Sahota, Z. Davis, T. J. Hamblin, and F. K. Stevenson Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia Blood, June 1, 2000; 95(11): 3534 - 3540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Callanan, P. Le Baccon, P. Mossuz, S. Duley, C. Bastard, R. Hamoudi, M. J. Dyer, G. Klobeck, R. Rimokh, J. J. Sotto, et al. The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma PNAS, January 4, 2000; 97(1): 309 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Harris, C.-C. Chang, M. T. Berton, N. N. Danial, J. Zhang, D. Kuehner, B. H. Ye, M. Kvatyuk, P. P. Pandolfi, G. Cattoretti, et al. Transcriptional Repression of Stat6-Dependent Interleukin-4-Induced Genes by BCL-6: Specific Regulation of Ivarepsilon Transcription and Immunoglobulin E Switching Mol. Cell. Biol., October 1, 1999; 19(10): 7264 - 7275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Daniel and A. B. Reynolds The Catenin p120ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor Mol. Cell. Biol., May 1, 1999; 19(5): 3614 - 3623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al. The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells Blood, August 1, 1998; 92(3): 1011 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Carbone, G. Gaidano, A. Gloghini, L. M. Larocca, D. Capello, V. Canzonieri, A. Antinori, U. Tirelli, B. Falini, and R. Dalla-Favera Differential Expression of BCL-6, CD138/Syndecan-1, and Epstein-Barr Virus-Encoded Latent Membrane Protein-1 Identifies Distinct Histogenetic Subsets of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas Blood, February 1, 1998; 91(3): 747 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, S. Iida, D. C. Louie, R. Dalla-Favera, and R.S.K. Chaganti Heterologous Promoters Fused to BCL6 by Chromosomal Translocations Affecting Band 3q27 Cause Its Deregulated Expression During B-Cell Differentiation Blood, January 15, 1998; 91(2): 603 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Carbone, A. Gloghini, G. Gaidano, R. Dalla-Favera, and B. Falini BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas Blood, September 15, 1997; 90(6): 2445 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nishida, A. Tamura, N. Nakazawa, Y. Ueda, T. Abe, F. Matsuda, K. Kashima, and M. Taniwaki The Ig Heavy Chain Gene Is Frequently Involved in Chromosomal Translocations in Multiple Myeloma and Plasma Cell Leukemia as Detected by In Situ Hybridization Blood, July 15, 1997; 90(2): 526 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gaidano, A. Carbone, C. Pastore, D. Capello, A. Migliazza, A. Gloghini, S. Roncella, M. Ferrarini, G. Saglio, and R. Dalla-Favera Frequent Mutation of the 5' Noncoding Region of the BCL-6 Gene in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas Blood, May 15, 1997; 89(10): 3755 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, G. Shao, G. Steele-Perkins, and S. Huang The Retinoblastoma Interacting Zinc Finger Gene RIZ Produces a PR Domain-lacking Product through an Internal Promoter J. Biol. Chem., January 31, 1997; 272(5): 2984 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Bergsagel, M. Chesi, E. Nardini, L. A. Brents, S. L. Kirby, and W. M. Kuehl Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma PNAS, November 26, 1996; 93(24): 13931 - 13936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Offit, F. L. Coco, D. C. Louie, N. Z. Parsa, D. Leung, C. Portlock, B. H. Ye, F. Lista, D. A. Filippa, A. Rosenbaum, et al. Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma N. Engl. J. Med., July 14, 1994; 331(2): 74 - 80. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Ye, F Lista, F Lo Coco, D. Knowles, K Offit, R. Chaganti, and R Dalla-Favera Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma Science, October 29, 1993; 262(5134): 747 - 750. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
